NeuroBo Pharmaceuticals, Inc. - Common Stock (NRBO)
2.3600
0.00 (0.00%)
Neurobo Pharmaceuticals is a biotechnology company focused on developing innovative therapies for neurodegenerative diseases and other severe conditions
Through its cutting-edge research and development efforts, the company aims to create transformative treatments that address significant unmet medical needs in areas such as cognition, memory, and overall brain health. By harnessing advanced technology and scientific insights, Neurobo strives to improve patient outcomes and enhance the quality of life for individuals affected by debilitating neurological disorders.